Tanaka Y - Search Results

1

Two Distinct Mechanisms Underlying γδ T Cell-Mediated Regulation of Collagen Type I in Lung Fibroblasts.

Okuno D, Sakamoto N, Akiyama Y, Tokito T, Hara A, Kido T, Ishimoto H, Ishimatsu Y, Tagod MSO, Okamura H, Tanaka Y, Mukae H. Okuno D, et al. Among authors: tanaka y. Cells. 2022 Sep 9;11(18):2816. doi: 10.3390/cells11182816. Cells. 2022. PMID: 36139391 Free PMC article.

2

Involvement of CD56brightCD11c+ cells in IL-18-mediated expansion of human γδ T cells.

Tsuda J, Li W, Yamanishi H, Yamamoto H, Okuda A, Kubo S, Ma Z, Terada N, Tanaka Y, Okamura H. Tsuda J, et al. Among authors: tanaka y. J Immunol. 2011 Feb 15;186(4):2003-12. doi: 10.4049/jimmunol.1001919. Epub 2011 Jan 14. J Immunol. 2011. PMID: 21239711

3

Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells.

Sugie T, Murata-Hirai K, Iwasaki M, Morita CT, Li W, Okamura H, Minato N, Toi M, Tanaka Y. Sugie T, et al. Among authors: tanaka y. Cancer Immunol Immunother. 2013 Apr;62(4):677-87. doi: 10.1007/s00262-012-1368-4. Epub 2012 Nov 15. Cancer Immunol Immunother. 2013. PMID: 23151944 Free PMC article.

4

[GammadeltaT cell therapy].

Tanaka Y, Okamura H. Tanaka Y, et al. Nihon Rinsho. 2012 Dec;70(12):2147-51. Nihon Rinsho. 2012. PMID: 23259388 Review. Japanese.

5

Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.

Idrees AS, Sugie T, Inoue C, Murata-Hirai K, Okamura H, Morita CT, Minato N, Toi M, Tanaka Y. Idrees AS, et al. Among authors: tanaka y. Cancer Sci. 2013 May;104(5):536-42. doi: 10.1111/cas.12124. Epub 2013 Mar 19. Cancer Sci. 2013. PMID: 23387443 Free PMC article.

6

[Anti-PD-1 antibody: basics and clinical application].

Tanaka Y, Okamura H. Tanaka Y, et al. Gan To Kagaku Ryoho. 2013 Sep;40(9):1145-9. Gan To Kagaku Ryoho. 2013. PMID: 24047772 Japanese.

7

Regulation of development of CD56 bright CD11c + NK-like cells with helper function by IL-18.

Li W, Okuda A, Yamamoto H, Yamanishi K, Terada N, Yamanishi H, Tanaka Y, Okamura H. Li W, et al. Among authors: tanaka y. PLoS One. 2013 Dec 20;8(12):e82586. doi: 10.1371/journal.pone.0082586. eCollection 2013. PLoS One. 2013. PMID: 24376549 Free PMC article.

8

Augmentation of Immune Checkpoint Cancer Immunotherapy with IL18.

Ma Z, Li W, Yoshiya S, Xu Y, Hata M, El-Darawish Y, Markova T, Yamanishi K, Yamanishi H, Tahara H, Tanaka Y, Okamura H. Ma Z, et al. Among authors: tanaka y. Clin Cancer Res. 2016 Jun 15;22(12):2969-80. doi: 10.1158/1078-0432.CCR-15-1655. Epub 2016 Jan 11. Clin Cancer Res. 2016. PMID: 26755531

9

Targeting Cancer Cells with a Bisphosphonate Prodrug.

Matsumoto K, Hayashi K, Murata-Hirai K, Iwasaki M, Okamura H, Minato N, Morita CT, Tanaka Y. Matsumoto K, et al. Among authors: tanaka y. ChemMedChem. 2016 Dec 16;11(24):2656-2663. doi: 10.1002/cmdc.201600465. Epub 2016 Oct 27. ChemMedChem. 2016. PMID: 27786425 Free PMC article.

10

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.

Tanaka Y, Iwasaki M, Murata-Hirai K, Matsumoto K, Hayashi K, Okamura H, Sugie T, Minato N, Morita CT, Toi M. Tanaka Y, et al. Sci Rep. 2017 Jul 20;7(1):5987. doi: 10.1038/s41598-017-05553-0. Sci Rep. 2017. PMID: 28729550 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,367 results

Search Page

Filters